BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sapone A, de Magistris L, Pietzak M, Clemente MG, Tripathi A, Cucca F, Lampis R, Kryszak D, Cartenì M, Generoso M. Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes. 2006;55:1443-1449. [PMID: 16644703 DOI: 10.2337/db05-1593] [Cited by in Crossref: 281] [Cited by in F6Publishing: 262] [Article Influence: 18.7] [Reference Citation Analysis]
Number Citing Articles
1 Gülden E, Wong FS, Wen L. The gut microbiota and Type 1 Diabetes. Clin Immunol 2015;159:143-53. [PMID: 26051037 DOI: 10.1016/j.clim.2015.05.013] [Cited by in Crossref: 96] [Cited by in F6Publishing: 70] [Article Influence: 16.0] [Reference Citation Analysis]
2 Cortez APB, Fisberg M, de Morais MB. Intestinal permeability and small intestine bacterial overgrowth in excess weight adolescents. Pediatr Obes 2021;16:e12741. [PMID: 33089672 DOI: 10.1111/ijpo.12741] [Reference Citation Analysis]
3 Wilms E, Gerritsen J, Smidt H, Besseling-van der Vaart I, Rijkers GT, Garcia Fuentes AR, Masclee AA, Troost FJ. Effects of Supplementation of the Synbiotic Ecologic® 825/FOS P6 on Intestinal Barrier Function in Healthy Humans: A Randomized Controlled Trial. PLoS One 2016;11:e0167775. [PMID: 27936169 DOI: 10.1371/journal.pone.0167775] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
4 Pearson JA, Agriantonis A, Wong FS, Wen L. Modulation of the immune system by the gut microbiota in the development of type 1 diabetes. Hum Vaccin Immunother 2018;14:2580-96. [PMID: 30156993 DOI: 10.1080/21645515.2018.1514354] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
5 Mathis D, Benoist C. The influence of the microbiota on type-1 diabetes: on the threshold of a leap forward in our understanding. Immunol Rev. 2012;245:239-249. [PMID: 22168424 DOI: 10.1111/j.1600-065x.2011.01084.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 38] [Article Influence: 6.8] [Reference Citation Analysis]
6 Spadoni I, Fornasa G, Rescigno M. Organ-specific protection mediated by cooperation between vascular and epithelial barriers. Nat Rev Immunol. 2017;17:761-773. [PMID: 28869253 DOI: 10.1038/nri.2017.100] [Cited by in Crossref: 61] [Cited by in F6Publishing: 49] [Article Influence: 15.3] [Reference Citation Analysis]
7 Zuo T, Cao L, Xue C, Tang Q. Dietary squid ink polysaccharide induces goblet cells to protect small intestine from chemotherapy induced injury. Food Funct 2015;6:981-6. [DOI: 10.1039/c4fo01191k] [Cited by in Crossref: 26] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
8 Lacerda JF, Lagos AC, Carolino E, Silva-Herdade AS, Silva M, Sousa Guerreiro C. Functional Food Components, Intestinal Permeability and Inflammatory Markers in Patients with Inflammatory Bowel Disease. Nutrients 2021;13:642. [PMID: 33669400 DOI: 10.3390/nu13020642] [Reference Citation Analysis]
9 Dirajlal-Fargo S, El-Kamari V, Weiner L, Shan L, Sattar A, Kulkarni M, Funderburg N, Nazzinda R, Karungi C, Kityo C, Musiime V, McComsey GA. Altered Intestinal Permeability and Fungal Translocation in Ugandan Children With Human Immunodeficiency Virus. Clin Infect Dis 2020;70:2413-22. [PMID: 31260509 DOI: 10.1093/cid/ciz561] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
10 Corsetti G, Romano C, Pasini E, Testa C, Dioguardi FS. Qualitative Nitrogen Malnutrition Damages Gut and Alters Microbiome in Adult Mice. A Preliminary Histopathological Study. Nutrients 2021;13:1089. [PMID: 33810512 DOI: 10.3390/nu13041089] [Reference Citation Analysis]
11 Işık Ü, Aydoğan Avşar P, Aktepe E, Doğuç DK, Kılıç F, Büyükbayram Hİ. Serum zonulin and claudin-5 levels in children with obsessive-compulsive disorder. Nord J Psychiatry 2020;74:346-51. [PMID: 31961248 DOI: 10.1080/08039488.2020.1715474] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
12 Mondal D, Minak J, Alam M, Liu Y, Dai J, Korpe P, Liu L, Haque R, Petri WA. Contribution of enteric infection, altered intestinal barrier function, and maternal malnutrition to infant malnutrition in Bangladesh. Clin Infect Dis. 2012;54:185-192. [PMID: 22109945 DOI: 10.1093/cid/cir807] [Cited by in Crossref: 174] [Cited by in F6Publishing: 150] [Article Influence: 17.4] [Reference Citation Analysis]
13 Haupt-Jorgensen M, Holm LJ, Josefsen K, Buschard K. Possible Prevention of Diabetes with a Gluten-Free Diet. Nutrients 2018;10:E1746. [PMID: 30428550 DOI: 10.3390/nu10111746] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
14 Nouri M, Bredberg A, Weström B, Lavasani S, Lees JR. Intestinal Barrier Dysfunction Develops at the Onset of Experimental Autoimmune Encephalomyelitis, and Can Be Induced by Adoptive Transfer of Auto-Reactive T Cells. PLoS ONE 2014;9:e106335. [DOI: 10.1371/journal.pone.0106335] [Cited by in Crossref: 92] [Cited by in F6Publishing: 83] [Article Influence: 13.1] [Reference Citation Analysis]
15 Visser J, Rozing J, Sapone A, Lammers K, Fasano A. Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms. Ann N Y Acad Sci. 2009;1165:195-205. [PMID: 19538307 DOI: 10.1111/j.1749-6632.2009.04037.x] [Cited by in Crossref: 141] [Cited by in F6Publishing: 117] [Article Influence: 11.8] [Reference Citation Analysis]
16 Priyadarshini M, Lednovich K, Xu K, Gough S, Wicksteed B, Layden BT. FFAR from the Gut Microbiome Crowd: SCFA Receptors in T1D Pathology. Metabolites 2021;11:302. [PMID: 34064625 DOI: 10.3390/metabo11050302] [Reference Citation Analysis]
17 Strewe C, Zeller R, Feuerecker M, Hoerl M, Matzel S, Kumprej I, Crispin A, Johannes B, Debevec T, Mekjavic IB, Eiken O, Thiel M, Schelling G, Choukèr A. PlanHab Study: Consequences of combined normobaric hypoxia and bed rest on adenosine kinetics. Sci Rep 2018;8:1762. [PMID: 29379127 DOI: 10.1038/s41598-018-20045-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
18 Valitutti F, Fasano A. Breaking Down Barriers: How Understanding Celiac Disease Pathogenesis Informed the Development of Novel Treatments. Dig Dis Sci 2019;64:1748-58. [PMID: 31076989 DOI: 10.1007/s10620-019-05646-y] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 14.5] [Reference Citation Analysis]
19 Diamanti A, Capriati T, Bizzarri C, Panetta F, Ferretti F, Ancinelli M, Romano F, Locatelli M. Celiac disease and endocrine autoimmune disorders in children: an update. Expert Review of Clinical Immunology 2014;9:1289-301. [DOI: 10.1586/1744666x.2013.850029] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Camilleri M, Lyle BJ, Madsen KL, Sonnenburg J, Verbeke K, Wu GD. Role for diet in normal gut barrier function: developing guidance within the framework of food-labeling regulations. Am J Physiol Gastrointest Liver Physiol 2019;317:G17-39. [PMID: 31125257 DOI: 10.1152/ajpgi.00063.2019] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 11.0] [Reference Citation Analysis]
21 Rittirsch D, Flierl MA, Nadeau BA, Day DE, Huber-Lang MS, Grailer JJ, Zetoune FS, Andjelkovic AV, Fasano A, Ward PA. Zonulin as prehaptoglobin2 regulates lung permeability and activates the complement system. Am J Physiol Lung Cell Mol Physiol 2013;304:L863-72. [PMID: 23564505 DOI: 10.1152/ajplung.00196.2012] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
22 Miranda-Ribera A, Ennamorati M, Serena G, Cetinbas M, Lan J, Sadreyev RI, Jain N, Fasano A, Fiorentino M. Exploiting the Zonulin Mouse Model to Establish the Role of Primary Impaired Gut Barrier Function on Microbiota Composition and Immune Profiles. Front Immunol 2019;10:2233. [PMID: 31608059 DOI: 10.3389/fimmu.2019.02233] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
23 Sofi MH, Johnson BM, Gudi RR, Jolly A, Gaudreau MC, Vasu C. Polysaccharide A-Dependent Opposing Effects of Mucosal and Systemic Exposures to Human Gut Commensal Bacteroides fragilis in Type 1 Diabetes. Diabetes 2019;68:1975-89. [PMID: 31311801 DOI: 10.2337/db19-0211] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
24 de Oliveira GLV, Leite AZ, Higuchi BS, Gonzaga MI, Mariano VS. Intestinal dysbiosis and probiotic applications in autoimmune diseases. Immunology. 2017;152:1-12. [PMID: 28556916 DOI: 10.1111/imm.12765] [Cited by in Crossref: 105] [Cited by in F6Publishing: 83] [Article Influence: 26.3] [Reference Citation Analysis]
25 Mokkala K, Tertti K, Rönnemaa T, Vahlberg T, Laitinen K. Evaluation of serum zonulin for use as an early predictor for gestational diabetes. Nutr Diabetes 2017;7:e253. [PMID: 28319108 DOI: 10.1038/nutd.2017.9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
26 Suzuki T. Regulation of intestinal epithelial permeability by tight junctions. Cell Mol Life Sci. 2013;70:631-659. [PMID: 22782113 DOI: 10.1007/s00018-012-1070-x] [Cited by in Crossref: 569] [Cited by in F6Publishing: 508] [Article Influence: 63.2] [Reference Citation Analysis]
27 Vorobjova T, Raikkerus H, Kadaja L, Talja I, Uibo O, Heilman K, Uibo R. Circulating Zonulin Correlates with Density of Enteroviruses and Tolerogenic Dendritic Cells in the Small Bowel Mucosa of Celiac Disease Patients. Dig Dis Sci 2017;62:358-71. [PMID: 27995404 DOI: 10.1007/s10620-016-4403-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
28 Liu Z, Kang L, Li C, Tong C, Huang M, Zhang X, Huang N, Moyer MP, Qin H, Wang J. Knockout of MIMP protein in lactobacillus plantarum lost its regulation of intestinal permeability on NCM460 epithelial cells through the zonulin pathway. BMC Gastroenterol 2014;14:171. [PMID: 25277875 DOI: 10.1186/1471-230X-14-171] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
29 Ohlsson B, Orho-Melander M, Nilsson PM. Higher Levels of Serum Zonulin May Rather Be Associated with Increased Risk of Obesity and Hyperlipidemia, Than with Gastrointestinal Symptoms or Disease Manifestations. Int J Mol Sci 2017;18:E582. [PMID: 28282855 DOI: 10.3390/ijms18030582] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 10.8] [Reference Citation Analysis]
30 Malyszko J, Koc-zorawska E, Levin-iaina N, Malyszko J. Zonulin, Iron Status, and Anemia in Kidney Transplant Recipients: Are They Related? Transplantation Proceedings 2014;46:2644-6. [DOI: 10.1016/j.transproceed.2014.09.018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
31 Santiago JL, Martínez A, Núñez C, de la Calle H, Fernández-arquero M, de la Concha EG, Urcelay E. Association of MYO9B haplotype with type 1 diabetes. Human Immunology 2008;69:112-5. [DOI: 10.1016/j.humimm.2008.01.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
32 Crookshank JA, Patrick C, Wang GS, Noel JA, Scott FW. Gut immune deficits in LEW.1AR1-iddm rats partially overcome by feeding a diabetes-protective diet. Immunology 2015;145:417-28. [PMID: 25711680 DOI: 10.1111/imm.12457] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
33 Antvorskov JC, Fundova P, Buschard K, Funda DP. Impact of dietary gluten on regulatory T cells and Th17 cells in BALB/c mice. PLoS One. 2012;7:e33315. [PMID: 22428018 DOI: 10.1371/journal.pone.0033315] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
34 Yu T, Lu XJ, Li JY, Shan TD, Huang CZ, Ouyang H, Yang HS, Xu JH, Zhong W, Xia ZS, Chen QK. Overexpression of miR-429 impairs intestinal barrier function in diabetic mice by down-regulating occludin expression. Cell Tissue Res 2016;366:341-52. [PMID: 27299781 DOI: 10.1007/s00441-016-2435-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 4.2] [Reference Citation Analysis]
35 Barceló A, Esquinas C, Robles J, Piérola J, De la Peña M, Aguilar I, Morell-Garcia D, Alonso A, Toledo N, Sánchez-de la Torre M, Barbé F. Gut epithelial barrier markers in patients with obstructive sleep apnea. Sleep Med 2016;26:12-5. [PMID: 28007354 DOI: 10.1016/j.sleep.2016.01.019] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
36 Demir E, Ozkan H, Seckin KD, Sahtiyancı B, Demir B, Tabak O, Kumbasar A, Uzun H. Plasma Zonulin Levels as a Non-Invasive Biomarker of Intestinal Permeability in Women with Gestational Diabetes Mellitus. Biomolecules 2019;9:E24. [PMID: 30641999 DOI: 10.3390/biom9010024] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
37 Leech B, Mcintyre E, Steel A, Sibbritt D. Risk factors associated with intestinal permeability in an adult population: A systematic review. Int J Clin Pract 2019;73. [DOI: 10.1111/ijcp.13385] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
38 Esnafoglu E, Cırrık S, Ayyıldız SN, Erdil A, Ertürk EY, Daglı A, Noyan T. Increased Serum Zonulin Levels as an Intestinal Permeability Marker in Autistic Subjects. J Pediatr 2017;188:240-4. [PMID: 28502607 DOI: 10.1016/j.jpeds.2017.04.004] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 10.8] [Reference Citation Analysis]
39 Odenwald MA, Turner JR. The intestinal epithelial barrier: a therapeutic target? Nat Rev Gastroenterol Hepatol. 2017;14:9-21. [PMID: 27848962 DOI: 10.1038/nrgastro.2016.169] [Cited by in Crossref: 324] [Cited by in F6Publishing: 295] [Article Influence: 64.8] [Reference Citation Analysis]
40 Saleem B, Okogbule-Wonodi AC, Fasano A, Magder LS, Ravel J, Kapoor S, Viscardi RM. Intestinal Barrier Maturation in Very Low Birthweight Infants: Relationship to Feeding and Antibiotic Exposure. J Pediatr 2017;183:31-36.e1. [PMID: 28159311 DOI: 10.1016/j.jpeds.2017.01.013] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
41 Power N, Turpin W, Espin-Garcia O, Smith MI, Croitoru K; CCC GEM Project Research Consortium. Serum Zonulin Measured by Commercial Kit Fails to Correlate With Physiologic Measures of Altered Gut Permeability in First Degree Relatives of Crohn's Disease Patients. Front Physiol 2021;12:645303. [PMID: 33841181 DOI: 10.3389/fphys.2021.645303] [Reference Citation Analysis]
42 Boerner BP, Sarvetnick NE. Type 1 diabetes: role of intestinal microbiome in humans and mice: Type 1 diabetes and intestinal microbiome. Annals of the New York Academy of Sciences 2011;1243:103-18. [DOI: 10.1111/j.1749-6632.2011.06340.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 53] [Article Influence: 6.3] [Reference Citation Analysis]
43 Tarko A, Suchojad A, Michalec M, Majcherczyk M, Brzozowska A, Maruniak-Chudek I. Zonulin: A Potential Marker of Intestine Injury in Newborns. Dis Markers 2017;2017:2413437. [PMID: 28769143 DOI: 10.1155/2017/2413437] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
44 Lindheim L, Bashir M, Münzker J, Trummer C, Zachhuber V, Leber B, Horvath A, Pieber TR, Gorkiewicz G, Stadlbauer V, Obermayer-pietsch B, Yu Y. Alterations in Gut Microbiome Composition and Barrier Function Are Associated with Reproductive and Metabolic Defects in Women with Polycystic Ovary Syndrome (PCOS): A Pilot Study. PLoS ONE 2017;12:e0168390. [DOI: 10.1371/journal.pone.0168390] [Cited by in Crossref: 105] [Cited by in F6Publishing: 84] [Article Influence: 26.3] [Reference Citation Analysis]
45 Rapin JR, Wiernsperger N. Possible links between intestinal permeability and food processing: A potential therapeutic niche for glutamine. Clinics (Sao Paulo). 2010;65:635-643. [PMID: 20613941 DOI: 10.1590/s1807-59322010000600012] [Cited by in Crossref: 28] [Cited by in F6Publishing: 13] [Article Influence: 3.1] [Reference Citation Analysis]
46 Vaarala O. Leaking gut in type 1 diabetes. Curr Opin Gastroenterol. 2008;24:701-706. [PMID: 19122519 DOI: 10.1097/mog.0b013e32830e6d98] [Cited by in Crossref: 77] [Cited by in F6Publishing: 36] [Article Influence: 6.4] [Reference Citation Analysis]
47 Assimakopoulos SF, Papageorgiou I, Charonis A. Enterocytes' tight junctions: From molecules to diseases. World J Gastrointest Pathophysiol 2011;2:123-37. [PMID: 22184542 DOI: 10.4291/wjgp.v2.i6.123] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 45] [Article Influence: 5.0] [Reference Citation Analysis]
48 Leite JA, Pessenda G, Guerra-Gomes IC, de Santana AKM, André Pereira C, Ribeiro Campos Costa F, Ramos SG, Simões Zamboni D, Caetano Faria AM, Candido de Almeida D, Olsen Saraiva Câmara N, Tostes RC, Santana Silva J, Carlos D. The DNA Sensor AIM2 Protects against Streptozotocin-Induced Type 1 Diabetes by Regulating Intestinal Homeostasis via the IL-18 Pathway. Cells 2020;9:E959. [PMID: 32295112 DOI: 10.3390/cells9040959] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
49 Chen YG, Cabrera SM, Jia S, Kaldunski ML, Kramer J, Cheong S, Geoffrey R, Roethle MF, Woodliff JE, Greenbaum CJ, Wang X, Hessner MJ. Molecular signatures differentiate immune states in type 1 diabetic families. Diabetes 2014;63:3960-73. [PMID: 24760139 DOI: 10.2337/db14-0214] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 6.6] [Reference Citation Analysis]
50 Mokkala K, Pellonperä O, Röytiö H, Pussinen P, Rönnemaa T, Laitinen K. Increased intestinal permeability, measured by serum zonulin, is associated with metabolic risk markers in overweight pregnant women. Metabolism 2017;69:43-50. [PMID: 28285651 DOI: 10.1016/j.metabol.2016.12.015] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 8.5] [Reference Citation Analysis]
51 Kuzma JN, Hagman DK, Cromer G, Breymeyer KL, Roth CL, Foster-Schubert KE, Holte SE, Weigle DS, Kratz M. Intraindividual Variation in Markers of Intestinal Permeability and Adipose Tissue Inflammation in Healthy Normal-Weight to Obese Adults. Cancer Epidemiol Biomarkers Prev 2019;28:610-5. [PMID: 30573517 DOI: 10.1158/1055-9965.EPI-18-0641] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
52 Mokkala K, Laitinen K, Röytiö H. Bifidobacterium lactis 420 and fish oil enhance intestinal epithelial integrity in Caco-2 cells. Nutrition Research 2016;36:246-52. [DOI: 10.1016/j.nutres.2015.11.014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
53 de Kort S, Keszthelyi D, Masclee AA. Leaky gut and diabetes mellitus: what is the link? Obes Rev. 2011;12:449-458. [PMID: 21382153 DOI: 10.1111/j.1467-789x.2010.00845.x] [Cited by in Crossref: 122] [Cited by in F6Publishing: 55] [Article Influence: 12.2] [Reference Citation Analysis]
54 Patterson E, Ryan PM, Cryan JF, Dinan TG, Ross RP, Fitzgerald GF, Stanton C. Gut microbiota, obesity and diabetes. Postgrad Med J. 2016;92:286-300. [PMID: 26912499 DOI: 10.1136/postgradmedj-2015-133285] [Cited by in Crossref: 148] [Cited by in F6Publishing: 128] [Article Influence: 29.6] [Reference Citation Analysis]
55 Sturgeon C, Lan J, Fasano A. Zonulin transgenic mice show altered gut permeability and increased morbidity/mortality in the DSS colitis model. Ann N Y Acad Sci 2017;1397:130-42. [PMID: 28423466 DOI: 10.1111/nyas.13343] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]
56 Ganda Mall JP, Östlund-Lagerström L, Lindqvist CM, Algilani S, Rasoal D, Repsilber D, Brummer RJ, Keita ÅV, Schoultz I. Are self-reported gastrointestinal symptoms among older adults associated with increased intestinal permeability and psychological distress? BMC Geriatr 2018;18:75. [PMID: 29554871 DOI: 10.1186/s12877-018-0767-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
57 Nguyen TD, Prykhodko O, Hållenius FF, Nyman M. Monobutyrin Reduces Liver Cholesterol and Improves Intestinal Barrier Function in Rats Fed High-Fat Diets. Nutrients 2019;11:E308. [PMID: 30717248 DOI: 10.3390/nu11020308] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 5.5] [Reference Citation Analysis]
58 Russo F, Linsalata M, Clemente C, Chiloiro M, Orlando A, Marconi E, Chimienti G, Riezzo G. Inulin-enriched pasta improves intestinal permeability and modifies the circulating levels of zonulin and glucagon-like peptide 2 in healthy young volunteers. Nutrition Research 2012;32:940-6. [DOI: 10.1016/j.nutres.2012.09.010] [Cited by in Crossref: 60] [Cited by in F6Publishing: 46] [Article Influence: 6.7] [Reference Citation Analysis]
59 Moreno-Navarrete JM, Sabater M, Ortega F, Ricart W, Fernández-Real JM. Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance. PLoS One. 2012;7:e37160. [PMID: 22629362 DOI: 10.1371/journal.pone.0037160] [Cited by in Crossref: 142] [Cited by in F6Publishing: 128] [Article Influence: 15.8] [Reference Citation Analysis]
60 Husain-Krautter S, Kramer JM, Li W, Guo B, Rothstein TL. The osteopontin transgenic mouse is a new model for Sjögren's syndrome. Clin Immunol 2015;157:30-42. [PMID: 25572532 DOI: 10.1016/j.clim.2014.12.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
61 Wang C, Weng Y, Tu W, Jin C, Jin Y. Maternal exposure to sodium ρ-perfluorous nonenoxybenzene sulfonate during pregnancy and lactation disrupts intestinal barrier and may cause obstacles to the nutrient transport and metabolism in F0 and F1 generations of mice. Sci Total Environ 2021;794:148775. [PMID: 34323766 DOI: 10.1016/j.scitotenv.2021.148775] [Reference Citation Analysis]
62 Hidalgo-Liberona N, González-Domínguez R, Vegas E, Riso P, Del Bo' C, Bernardi S, Peron G, Guglielmetti S, Gargari G, Kroon PA, Cherubini A, Andrés-Lacueva C. Increased Intestinal Permeability in Older Subjects Impacts the Beneficial Effects of Dietary Polyphenols by Modulating Their Bioavailability. J Agric Food Chem 2020;68:12476-84. [PMID: 33084335 DOI: 10.1021/acs.jafc.0c04976] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
63 Dumitrescu L, Marta D, Dănău A, Lefter A, Tulbă D, Cozma L, Manole E, Gherghiceanu M, Ceafalan LC, Popescu BO. Serum and Fecal Markers of Intestinal Inflammation and Intestinal Barrier Permeability Are Elevated in Parkinson's Disease. Front Neurosci 2021;15:689723. [PMID: 34220443 DOI: 10.3389/fnins.2021.689723] [Reference Citation Analysis]
64 Loffredo L, Ettorre E, Zicari AM, Inghilleri M, Nocella C, Perri L, Spalice A, Fossati C, De Lucia MC, Pigozzi F, Cacciafesta M, Violi F, Carnevale R; Neurodegenerative Disease study group . Oxidative Stress and Gut-Derived Lipopolysaccharides in Neurodegenerative Disease: Role of NOX2. Oxid Med Cell Longev 2020;2020:8630275. [PMID: 32089785 DOI: 10.1155/2020/8630275] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
65 Anton G, Peltecu G, Socolov D, Cornitescu F, Bleotu C, Sgarbura Z, Teleman S, Iliescu D, Botezatu A, Goia CD, Huica I, Anton AC. Type-specific human papillomavirus detection in cervical smears in Romania. APMIS 2011;119:1-9. [PMID: 21143521 DOI: 10.1111/j.1600-0463.2010.02641.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
66 Ballotti S, de Martino M. Rotavirus infections and development of type 1 diabetes: an evasive conundrum. J Pediatr Gastroenterol Nutr 2007;45:147-56. [PMID: 17667707 DOI: 10.1097/MPG.0b013e31805fc256] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
67 Cabello-Olmo M, Oneca M, Torre P, Sainz N, Moreno-Aliaga MJ, Guruceaga E, Díaz JV, Encio IJ, Barajas M, Araña M. A Fermented Food Product Containing Lactic Acid Bacteria Protects ZDF Rats from the Development of Type 2 Diabetes. Nutrients 2019;11:E2530. [PMID: 31635188 DOI: 10.3390/nu11102530] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
68 Groschwitz KR, Wu D, Osterfeld H, Ahrens R, Hogan SP. Chymase-mediated intestinal epithelial permeability is regulated by a protease-activating receptor/matrix metalloproteinase-2-dependent mechanism. Am J Physiol Gastrointest Liver Physiol. 2013;304:G479-G489. [PMID: 23306080 DOI: 10.1152/ajpgi.00186.2012] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 5.8] [Reference Citation Analysis]
69 Passali M, Josefsen K, Frederiksen JL, Antvorskov JC. Current Evidence on the Efficacy of Gluten-Free Diets in Multiple Sclerosis, Psoriasis, Type 1 Diabetes and Autoimmune Thyroid Diseases. Nutrients 2020;12:E2316. [PMID: 32752175 DOI: 10.3390/nu12082316] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
70 Fasano A. Physiological, pathological, and therapeutic implications of zonulin-mediated intestinal barrier modulation: living life on the edge of the wall. Am J Pathol. 2008;173:1243-1252. [PMID: 18832585 DOI: 10.2353/ajpath.2008.080192] [Cited by in Crossref: 59] [Cited by in F6Publishing: 48] [Article Influence: 4.5] [Reference Citation Analysis]
71 Liu ZH, Kang L, Wang JP. Basic and clinical research on the regulation of the intestinal barrier by Lactobacillus and its active protein components: a review with experience of one center. Mol Biol Rep 2014;41:8037-46. [PMID: 25185994 DOI: 10.1007/s11033-014-3701-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
72 Bosi E, Molteni L, Radaelli MG, Folini L, Fermo I, Bazzigaluppi E, Piemonti L, Pastore MR, Paroni R. Increased intestinal permeability precedes clinical onset of type 1 diabetes. Diabetologia 2006;49:2824-7. [PMID: 17028899 DOI: 10.1007/s00125-006-0465-3] [Cited by in Crossref: 245] [Cited by in F6Publishing: 206] [Article Influence: 16.3] [Reference Citation Analysis]
73 Atkinson MA, Chervonsky A. Does the gut microbiota have a role in type 1 diabetes? Early evidence from humans and animal models of the disease. Diabetologia. 2012;55:2868-2877. [PMID: 22875196 DOI: 10.1007/s00125-012-2672-4] [Cited by in Crossref: 66] [Cited by in F6Publishing: 57] [Article Influence: 7.3] [Reference Citation Analysis]
74 Bruun SW, Josefsen K, Tanassi JT, Marek A, Pedersen MH, Sidenius U, Haupt-Jorgensen M, Antvorskov JC, Larsen J, Heegaard NH, Buschard K. Large Gliadin Peptides Detected in the Pancreas of NOD and Healthy Mice following Oral Administration. J Diabetes Res 2016;2016:2424306. [PMID: 27795959 DOI: 10.1155/2016/2424306] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
75 Joesten WC, Short AH, Kennedy MA. Spatial variations in gut permeability are linked to type 1 diabetes development in non-obese diabetic mice. BMJ Open Diabetes Res Care 2019;7:e000793. [PMID: 31908796 DOI: 10.1136/bmjdrc-2019-000793] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
76 van IJzendoorn SCD, Derkinderen P. The Intestinal Barrier in Parkinson's Disease: Current State of Knowledge. J Parkinsons Dis 2019;9:S323-9. [PMID: 31561386 DOI: 10.3233/JPD-191707] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 17.0] [Reference Citation Analysis]
77 Fasano A. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol Rev. 2011;91:151-175. [PMID: 21248165 DOI: 10.1152/physrev.00003.2008] [Cited by in Crossref: 403] [Cited by in F6Publishing: 316] [Article Influence: 40.3] [Reference Citation Analysis]
78 Kinashi Y, Hase K. Partners in Leaky Gut Syndrome: Intestinal Dysbiosis and Autoimmunity. Front Immunol 2021;12:673708. [PMID: 33968085 DOI: 10.3389/fimmu.2021.673708] [Reference Citation Analysis]
79 Aydoğan Avşar P, Işık Ü, Aktepe E, Kılıç F, Doğuç DK, Büyükbayram Hİ. Serum zonulin and claudin-5 levels in children with attention-deficit/hyperactivity disorder. Int J Psychiatry Clin Pract 2021;25:49-55. [PMID: 32757874 DOI: 10.1080/13651501.2020.1801754] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
80 Wood Heickman LK, DeBoer MD, Fasano A. Zonulin as a potential putative biomarker of risk for shared type 1 diabetes and celiac disease autoimmunity. Diabetes Metab Res Rev 2020;36:e3309. [PMID: 32162764 DOI: 10.1002/dmrr.3309] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
81 Chander AM, Yadav H, Jain S, Bhadada SK, Dhawan DK. Cross-Talk Between Gluten, Intestinal Microbiota and Intestinal Mucosa in Celiac Disease: Recent Advances and Basis of Autoimmunity. Front Microbiol. 2018;9:2597. [PMID: 30443241 DOI: 10.3389/fmicb.2018.02597] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 7.3] [Reference Citation Analysis]
82 Arrieta MC, Bistritz L, Meddings JB. Alterations in intestinal permeability. Gut. 2006;55:1512-1520. [PMID: 16966705 DOI: 10.1136/gut. 2005.085373] [Reference Citation Analysis]
83 Hu C, Wong FS, Wen L. Type 1 diabetes and gut microbiota: Friend or foe? Pharmacol Res 2015;98:9-15. [PMID: 25747961 DOI: 10.1016/j.phrs.2015.02.006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 4.7] [Reference Citation Analysis]
84 Groschwitz KR, Ahrens R, Osterfeld H, Gurish MF, Han X, Abrink M, Finkelman FD, Pejler G, Hogan SP. Mast cells regulate homeostatic intestinal epithelial migration and barrier function by a chymase/Mcpt4-dependent mechanism. Proc Natl Acad Sci USA. 2009;106:22381-22386. [PMID: 20018751 DOI: 10.1073/pnas.0906372106] [Cited by in Crossref: 107] [Cited by in F6Publishing: 103] [Article Influence: 8.9] [Reference Citation Analysis]
85 Cabrera SM, Henschel AM, Hessner MJ. Innate inflammation in type 1 diabetes. Transl Res 2016;167:214-27. [PMID: 25980926 DOI: 10.1016/j.trsl.2015.04.011] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 7.0] [Reference Citation Analysis]
86 Sturgeon C, Fasano A. Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases. Tissue Barriers 2016;4:e1251384. [PMID: 28123927 DOI: 10.1080/21688370.2016.1251384] [Cited by in Crossref: 136] [Cited by in F6Publishing: 99] [Article Influence: 27.2] [Reference Citation Analysis]
87 Linsalata M, Riezzo G, Clemente C, D'Attoma B, Russo F. Noninvasive Biomarkers of Gut Barrier Function in Patients Suffering from Diarrhea Predominant-IBS: An Update. Dis Markers 2020;2020:2886268. [PMID: 33110455 DOI: 10.1155/2020/2886268] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
88 Liu Z, Huang M, Zhang X, Wang L, Huang N, Peng H, Lan P, Peng J, Yang Z, Xia Y, Liu W, Yang J, Qin H, Wang J. The effects of perioperative probiotic treatment on serum zonulin concentration and subsequent postoperative infectious complications after colorectal cancer surgery: a double-center and double-blind randomized clinical trial. The American Journal of Clinical Nutrition 2013;97:117-26. [DOI: 10.3945/ajcn.112.040949] [Cited by in Crossref: 93] [Cited by in F6Publishing: 74] [Article Influence: 10.3] [Reference Citation Analysis]
89 Pérez-Reytor D, Puebla C, Karahanian E, García K. Use of Short-Chain Fatty Acids for the Recovery of the Intestinal Epithelial Barrier Affected by Bacterial Toxins. Front Physiol 2021;12:650313. [PMID: 34108884 DOI: 10.3389/fphys.2021.650313] [Reference Citation Analysis]
90 Harms RZ, Lorenzo KM, Corley KP, Cabrera MS, Sarvetnick NE. Altered CD161 bright CD8+ mucosal associated invariant T (MAIT)-like cell dynamics and increased differentiation states among juvenile type 1 diabetics. PLoS One. 2015;10:e0117335. [PMID: 25625430 DOI: 10.1371/journal.pone.0117335] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
91 Hwang D, Jo H, Hwang S, Kim JK, Kim IH, Lim YH. Conditioned medium from LS 174T goblet cells treated with oxyresveratrol strengthens tight junctions in Caco-2 cells. Biomed Pharmacother 2017;85:280-6. [PMID: 27876210 DOI: 10.1016/j.biopha.2016.11.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
92 Stenman LK, Lehtinen MJ, Meland N, Christensen JE, Yeung N, Saarinen MT, Courtney M, Burcelin R, Lähdeaho ML, Linros J, Apter D, Scheinin M, Kloster Smerud H, Rissanen A, Lahtinen S. Probiotic With or Without Fiber Controls Body Fat Mass, Associated With Serum Zonulin, in Overweight and Obese Adults-Randomized Controlled Trial. EBioMedicine 2016;13:190-200. [PMID: 27810310 DOI: 10.1016/j.ebiom.2016.10.036] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 11.6] [Reference Citation Analysis]
93 Stojanović I, Saksida T, Miljković Đ, Pejnović N. Modulation of Intestinal ILC3 for the Treatment of Type 1 Diabetes. Front Immunol 2021;12:653560. [PMID: 34149694 DOI: 10.3389/fimmu.2021.653560] [Reference Citation Analysis]
94 Richards JL, Yap YA, McLeod KH, Mackay CR, Mariño E. Dietary metabolites and the gut microbiota: an alternative approach to control inflammatory and autoimmune diseases. Clin Transl Immunology 2016;5:e82. [PMID: 27350881 DOI: 10.1038/cti.2016.29] [Cited by in Crossref: 104] [Cited by in F6Publishing: 92] [Article Influence: 20.8] [Reference Citation Analysis]
95 Vangoitsenhoven R, Cresci GAM. Role of Microbiome and Antibiotics in Autoimmune Diseases. Nutrition in Clinical Practice 2020;35:406-16. [DOI: 10.1002/ncp.10489] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
96 Punaro GR, Maciel FR, Rodrigues AM, Rogero MM, Bogsan CS, Oliveira MN, Ihara SS, Araujo SR, Sanches TR, Andrade LC, Higa EM. Kefir administration reduced progression of renal injury in STZ-diabetic rats by lowering oxidative stress. Nitric Oxide 2014;37:53-60. [DOI: 10.1016/j.niox.2013.12.012] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 4.9] [Reference Citation Analysis]
97 Lukaszyk E, Lukaszyk M, Koc-Zorawska E, Bodzenta-Lukaszyk A, Malyszko J. Zonulin, inflammation and iron status in patients with early stages of chronic kidney disease. Int Urol Nephrol 2018;50:121-5. [PMID: 29134616 DOI: 10.1007/s11255-017-1741-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
98 Harbison JE, Roth-Schulze AJ, Giles LC, Tran CD, Ngui KM, Penno MA, Thomson RL, Wentworth JM, Colman PG, Craig ME, Morahan G, Papenfuss AT, Barry SC, Harrison LC, Couper JJ. Gut microbiome dysbiosis and increased intestinal permeability in children with islet autoimmunity and type 1 diabetes: A prospective cohort study. Pediatr Diabetes 2019;20:574-83. [PMID: 31081243 DOI: 10.1111/pedi.12865] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 13.5] [Reference Citation Analysis]
99 Kaczmarczyk M, Löber U, Adamek K, Węgrzyn D, Skonieczna-Żydecka K, Malinowski D, Łoniewski I, Markó L, Ulas T, Forslund SK, Łoniewska B. The gut microbiota is associated with the small intestinal paracellular permeability and the development of the immune system in healthy children during the first two years of life. J Transl Med 2021;19:177. [PMID: 33910577 DOI: 10.1186/s12967-021-02839-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
100 Duerksen DR, Wilhelm-Boyles C, Veitch R, Kryszak D, Parry DM. A comparison of antibody testing, permeability testing, and zonulin levels with small-bowel biopsy in celiac disease patients on a gluten-free diet. Dig Dis Sci. 2010;55:1026-1031. [PMID: 19399613 DOI: 10.1007/s10620-009-0813-5] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
101 Vanuytsel T, Vermeire S, Cleynen I. The role of Haptoglobin and its related protein, Zonulin, in inflammatory bowel disease. Tissue Barriers. 2013;1:e27321. [PMID: 24868498 DOI: 10.4161/tisb.27321] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 8.1] [Reference Citation Analysis]
102 Dong S, Singh TP, Wei X, Yao H, Wang H. Protective Effect of 1,25-Dihydroxy Vitamin D3 on Pepsin-Trypsin-Resistant Gliadin-Induced Tight Junction Injuries. Dig Dis Sci 2018;63:92-104. [PMID: 28871457 DOI: 10.1007/s10620-017-4738-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
103 Vaquero L, Bernardo D, León F, Rodríguez-martín L, Alvarez-cuenllas B, Vivas S. Challenges to drug discovery for celiac disease and approaches to overcome them. Expert Opinion on Drug Discovery 2019;14:957-68. [DOI: 10.1080/17460441.2019.1642321] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
104 Zhang L, Masetti G, Colucci G, Salvi M, Covelli D, Eckstein A, Kaiser U, Draman MS, Muller I, Ludgate M, Lucini L, Biscarini F. Combining micro-RNA and protein sequencing to detect robust biomarkers for Graves' disease and orbitopathy. Sci Rep 2018;8:8386. [PMID: 29849043 DOI: 10.1038/s41598-018-26700-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
105 Chaiyasut C, Sivamaruthi BS, Kesika P, Khongtan S, Khampithum N, Thangaleela S, Peerajan S, Bumrungpert A, Chaiyasut K, Sirilun S, Sittiprapaporn P. Synbiotic Supplementation Improves Obesity Index and Metabolic Biomarkers in Thai Obese Adults: A Randomized Clinical Trial. Foods 2021;10:1580. [PMID: 34359450 DOI: 10.3390/foods10071580] [Reference Citation Analysis]
106 Putt KK, Pei R, White HM, Bolling BW. Yogurt inhibits intestinal barrier dysfunction in Caco-2 cells by increasing tight junctions. Food Funct 2017;8:406-14. [PMID: 28091645 DOI: 10.1039/c6fo01592a] [Cited by in Crossref: 36] [Cited by in F6Publishing: 15] [Article Influence: 12.0] [Reference Citation Analysis]
107 De Munck TJI, Xu P, Verwijs HJA, Masclee AAM, Jonkers D, Verbeek J, Koek GH. Intestinal permeability in human nonalcoholic fatty liver disease: A systematic review and meta-analysis. Liver Int 2020;40:2906-16. [PMID: 33037768 DOI: 10.1111/liv.14696] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
108 Knudsen JK, Leutscher P, Sørensen S. Gut Microbiota in Bone Health and Diabetes. Curr Osteoporos Rep 2021;19:462-79. [PMID: 33523423 DOI: 10.1007/s11914-020-00629-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
109 Wells JM, Brummer RJ, Derrien M, MacDonald TT, Troost F, Cani PD, Theodorou V, Dekker J, Méheust A, de Vos WM, Mercenier A, Nauta A, Garcia-Rodenas CL. Homeostasis of the gut barrier and potential biomarkers. Am J Physiol Gastrointest Liver Physiol 2017;312:G171-93. [PMID: 27908847 DOI: 10.1152/ajpgi.00048.2015] [Cited by in Crossref: 188] [Cited by in F6Publishing: 153] [Article Influence: 37.6] [Reference Citation Analysis]
110 Scheffler L, Crane A, Heyne H, Tönjes A, Schleinitz D, Ihling CH, Stumvoll M, Freire R, Fiorentino M, Fasano A, Kovacs P, Heiker JT. Widely Used Commercial ELISA Does Not Detect Precursor of Haptoglobin2, but Recognizes Properdin as a Potential Second Member of the Zonulin Family. Front Endocrinol (Lausanne) 2018;9:22. [PMID: 29459849 DOI: 10.3389/fendo.2018.00022] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 13.3] [Reference Citation Analysis]
111 Zhu MJ, Du M, Ford SP. CELL BIOLOGY SYMPOSIUM: Impacts of maternal obesity on placental and gut inflammation and health. J Anim Sci 2014;92:1840-9. [PMID: 24243902 DOI: 10.2527/jas.2013-7106] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
112 Wang MJ, Xu XL, Yao GL, Yu Q, Zhu CF, Kong ZJ, Zhao H, Tang LM, Qin XH. MYO9B gene polymorphisms are associated with the risk of inflammatory bowel diseases. Oncotarget 2016;7:58862-75. [PMID: 27556856 DOI: 10.18632/oncotarget.11186] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
113 Kim JH, Heo JS, Baek KS, Kim S, Kim JH, Baek K, Kim KE, Sheen YH. Zonulin level, a marker of intestinal permeability, is increased in association with liver enzymes in young adolescents. Clinica Chimica Acta 2018;481:218-24. [DOI: 10.1016/j.cca.2018.03.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
114 Das P, Goswami P, Das TK, Nag T, Sreenivas V, Ahuja V, Panda SK, Gupta SD, Makharia GK. Comparative tight junction protein expressions in colonic Crohn’s disease, ulcerative colitis, and tuberculosis: a new perspective. Virchows Arch 2012;460:261-70. [DOI: 10.1007/s00428-012-1195-1] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 6.0] [Reference Citation Analysis]
115 Nunes C, Freitas V, Almeida L, Laranjinha J. Red wine extract preserves tight junctions in intestinal epithelial cells under inflammatory conditions: implications for intestinal inflammation. Food Funct 2019;10:1364-74. [PMID: 30735221 DOI: 10.1039/c8fo02469c] [Cited by in Crossref: 33] [Cited by in F6Publishing: 16] [Article Influence: 16.5] [Reference Citation Analysis]
116 Vancamelbeke M, Vermeire S. The intestinal barrier: a fundamental role in health and disease. Expert Rev Gastroenterol Hepatol. 2017;11:821-834. [PMID: 28650209 DOI: 10.1080/17474124.2017.1343143] [Cited by in Crossref: 234] [Cited by in F6Publishing: 185] [Article Influence: 58.5] [Reference Citation Analysis]
117 Xu Y, Li Y, Scott K, Lindh CH, Jakobsson K, Fletcher T, Ohlsson B, Andersson EM. Inflammatory bowel disease and biomarkers of gut inflammation and permeability in a community with high exposure to perfluoroalkyl substances through drinking water. Environ Res 2020;181:108923. [PMID: 31759646 DOI: 10.1016/j.envres.2019.108923] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
118 Arrieta MC, Bistritz L, Meddings JB. Alterations in intestinal permeability. Gut. 2006;55:1512-1520. [PMID: 16966705 DOI: 10.1136/gut.2005.085373] [Cited by in Crossref: 358] [Cited by in F6Publishing: 313] [Article Influence: 27.5] [Reference Citation Analysis]
119 Rodrigues CF, Rodrigues ME, Henriques M. Candida sp. Infections in Patients with Diabetes Mellitus. J Clin Med. 2019;8. [PMID: 30634716 DOI: 10.3390/jcm8010076] [Cited by in Crossref: 55] [Cited by in F6Publishing: 34] [Article Influence: 27.5] [Reference Citation Analysis]
120 Fenneman AC, Rampanelli E, Yin YS, Ames J, Blaser MJ, Fliers E, Nieuwdorp M. Gut microbiota and metabolites in the pathogenesis of endocrine disease. Biochemical Society Transactions 2020;48:915-31. [DOI: 10.1042/bst20190686] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 12.0] [Reference Citation Analysis]
121 Gürsoy S, Koçkar T, Atik SU, Önal Z, Önal H, Adal E. Autoimmunity and intestinal colonization by Candida albicans in patients with type 1 diabetes at the time of the diagnosis. Korean J Pediatr 2018;61:217-20. [PMID: 30032588 DOI: 10.3345/kjp.2018.61.7.217] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
122 Matheus VA, Monteiro L, Oliveira RB, Maschio DA, Collares-Buzato CB. Butyrate reduces high-fat diet-induced metabolic alterations, hepatic steatosis and pancreatic beta cell and intestinal barrier dysfunctions in prediabetic mice. Exp Biol Med (Maywood) 2017;242:1214-26. [PMID: 28504618 DOI: 10.1177/1535370217708188] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 12.3] [Reference Citation Analysis]
123 Peters A, Wekerle H. Autoimmune diabetes mellitus and the leaky gut. Proc Natl Acad Sci U S A 2019;116:14788-90. [PMID: 31289225 DOI: 10.1073/pnas.1909224116] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
124 Wang L, Llorente C, Hartmann P, Yang AM, Chen P, Schnabl B. Methods to determine intestinal permeability and bacterial translocation during liver disease. J Immunol Methods. 2015;421:44-53. [PMID: 25595554 DOI: 10.1016/j.jim.2014.12.015] [Cited by in Crossref: 127] [Cited by in F6Publishing: 104] [Article Influence: 21.2] [Reference Citation Analysis]
125 Villanueva-Ortega E, Ahedo B, Fonseca-Sánchez MA, Pérez-Durán J, Garibay-Nieto N, Macías-Galavíz MT, Trujillo-Cabrera Y, García-Latorre E, Queipo G. Analysis of PTPN22, ZFAT and MYO9B polymorphisms in Turner Syndrome and risk of autoimmune disease. Int J Immunogenet 2017;44:153-7. [PMID: 28627089 DOI: 10.1111/iji.12323] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
126 Bodin J, Stene LC, Nygaard UC. Can exposure to environmental chemicals increase the risk of diabetes type 1 development? Biomed Res Int. 2015;2015:208947. [PMID: 25883945 DOI: 10.1155/2015/208947] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 8.0] [Reference Citation Analysis]
127 Martinez EE, Zurakowski D, Pereira L, Freire R, Emans JB, Nurko S, Duggan CP, Fasano A, Mehta NM. Interleukin-10 and Zonulin Are Associated With Postoperative Delayed Gastric Emptying in Critically Ill Surgical Pediatric Patients: A Prospective Pilot Study. JPEN J Parenter Enteral Nutr 2020;44:1407-16. [PMID: 32386238 DOI: 10.1002/jpen.1874] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
128 Bernardi S, Del Bo' C, Marino M, Gargari G, Cherubini A, Andrés-Lacueva C, Hidalgo-Liberona N, Peron G, González-Dominguez R, Kroon P, Kirkup B, Porrini M, Guglielmetti S, Riso P. Polyphenols and Intestinal Permeability: Rationale and Future Perspectives. J Agric Food Chem 2020;68:1816-29. [PMID: 31265272 DOI: 10.1021/acs.jafc.9b02283] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 12.5] [Reference Citation Analysis]
129 Tatucu-Babet OA, Forsyth A, Owen E, Navarro-Perez D, Radcliffe J, Benheim D, Mendis H, Jois M, Itsiopoulos C, Tierney AC. Serum zonulin measured by enzyme-linked immunosorbent assay may not be a reliable marker of small intestinal permeability in healthy adults. Nutr Res 2020;78:82-92. [PMID: 32563954 DOI: 10.1016/j.nutres.2020.05.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
130 Basolo A, Hohenadel M, Ang QY, Piaggi P, Heinitz S, Walter M, Walter P, Parrington S, Trinidad DD, von Schwartzenberg RJ, Turnbaugh PJ, Krakoff J. Effects of underfeeding and oral vancomycin on gut microbiome and nutrient absorption in humans. Nat Med 2020;26:589-98. [PMID: 32235930 DOI: 10.1038/s41591-020-0801-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 18.0] [Reference Citation Analysis]
131 Tomkin GH. The intestine as a regulator of cholesterol homeostasis in diabetes. Atheroscler Suppl. 2008;9:27-32. [PMID: 18693145 DOI: 10.1016/j.atherosclerosissup.2008.05.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
132 Soyucen E, Gulcan A, Aktuglu-Zeybek AC, Onal H, Kiykim E, Aydin A. Differences in the gut microbiota of healthy children and those with type 1 diabetes. Pediatr Int 2014;56:336-43. [PMID: 24475780 DOI: 10.1111/ped.12243] [Cited by in Crossref: 75] [Cited by in F6Publishing: 70] [Article Influence: 10.7] [Reference Citation Analysis]
133 Cangemi R, Della Valle P, Calvieri C, Taliani G, Ferroni P, Falcone M, Carnevale R, Bartimoccia S, D'Angelo A, Violi F; SIXTUS Study Group. Low-grade endotoxemia and clotting activation in the early phase of pneumonia. Respirology 2016;21:1465-71. [PMID: 27403788 DOI: 10.1111/resp.12854] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
134 Schoultz I, Keita ÅV. The Intestinal Barrier and Current Techniques for the Assessment of Gut Permeability. Cells 2020;9:E1909. [PMID: 32824536 DOI: 10.3390/cells9081909] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 24.0] [Reference Citation Analysis]
135 Forsgård RA, Korpela R, Holma R, Lindén J, Frias R, Spillmann T, Österlund P. Intestinal permeability to iohexol as an in vivo marker of chemotherapy-induced gastrointestinal toxicity in Sprague-Dawley rats. Cancer Chemother Pharmacol 2016;78:863-74. [PMID: 27590707 DOI: 10.1007/s00280-016-3150-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
136 Aravindhan V, Mohan V, Arunkumar N, Sandhya S, Babu S. Chronic Endotoxemia in Subjects with Type-1 Diabetes Is Seen Much before the Onset of Microvascular Complications. PLoS One 2015;10:e0137618. [PMID: 26367738 DOI: 10.1371/journal.pone.0137618] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
137 Groschwitz KR, Hogan SP. Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol 2009;124:3-20; quiz 21-2. [PMID: 19560575 DOI: 10.1016/j.jaci.2009.05.038] [Cited by in Crossref: 794] [Cited by in F6Publishing: 671] [Article Influence: 66.2] [Reference Citation Analysis]
138 Sakly W, Mankaï A, Sakly N, Thabet Y, Achour A, Ghedira-Besbes L, Jeddi M, Ghedira I. Anti-Saccharomyces cerevisiae antibodies are frequent in type 1 diabetes. Endocr Pathol. 2010;21:108-114. [PMID: 20387011 DOI: 10.1007/s12022-010-9118-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
139 Holland AM, Hyatt HW, Smuder AJ, Sollanek KJ, Morton AB, Roberts MD, Kavazis AN. Influence of endurance exercise training on antioxidant enzymes, tight junction proteins, and inflammatory markers in the rat ileum. BMC Res Notes 2015;8:514. [PMID: 26423686 DOI: 10.1186/s13104-015-1500-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
140 Lingaiah S, Arffman RK, Morin-Papunen L, Tapanainen JS, Piltonen T. Markers of gastrointestinal permeability and dysbiosis in premenopausal women with PCOS: a case-control study. BMJ Open 2021;11:e045324. [PMID: 34226215 DOI: 10.1136/bmjopen-2020-045324] [Reference Citation Analysis]
141 Eum SY, Jaraki D, Bertrand L, András IE, Toborek M. Disruption of epithelial barrier by quorum-sensing N-3-(oxododecanoyl)-homoserine lactone is mediated by matrix metalloproteinases. Am J Physiol Gastrointest Liver Physiol 2014;306:G992-G1001. [PMID: 24742991 DOI: 10.1152/ajpgi.00016.2014] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 4.7] [Reference Citation Analysis]
142 Davis-Richardson AG, Triplett EW. A model for the role of gut bacteria in the development of autoimmunity for type 1 diabetes. Diabetologia 2015;58:1386-93. [PMID: 25957231 DOI: 10.1007/s00125-015-3614-8] [Cited by in Crossref: 69] [Cited by in F6Publishing: 57] [Article Influence: 11.5] [Reference Citation Analysis]
143 Wegh CAM, de Roos NM, Hovenier R, Meijerink J, Besseling-van der Vaart I, van Hemert S, Witteman BJM. Intestinal Permeability Measured by Urinary Sucrose Excretion Correlates with Serum Zonulin and Faecal Calprotectin Concentrations in UC Patients in Remission. J Nutr Metab. 2019;2019:2472754. [PMID: 31061734 DOI: 10.1155/2019/2472754] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
144 Pražnikar ZJ, Kenig S, Vardjan T, Bizjak MČ, Petelin A. Effects of kefir or milk supplementation on zonulin in overweight subjects. J Dairy Sci 2020;103:3961-70. [PMID: 32171508 DOI: 10.3168/jds.2019-17696] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
145 Vorobjova T, Uibo O, Ojakivi I, Teesalu K, Panarina M, Heilman K, Uibo R. Lower expression of tight junction protein 1 gene and increased FOXP3 expression in the small bowel mucosa in coeliac disease and associated type 1 diabetes mellitus. Int Arch Allergy Immunol 2011;156:451-61. [PMID: 21832836 DOI: 10.1159/000324456] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
146 Visser JT, Lammers K, Hoogendijk A, Boer MW, Brugman S, Beijer-Liefers S, Zandvoort A, Harmsen H, Welling G, Stellaard F, Bos NA, Fasano A, Rozing J. Restoration of impaired intestinal barrier function by the hydrolysed casein diet contributes to the prevention of type 1 diabetes in the diabetes-prone BioBreeding rat. Diabetologia 2010;53:2621-8. [PMID: 20853098 DOI: 10.1007/s00125-010-1903-9] [Cited by in Crossref: 73] [Cited by in F6Publishing: 70] [Article Influence: 6.6] [Reference Citation Analysis]
147 Fasano A. Leaky gut and autoimmune diseases. Clin Rev Allergy Immunol. 2012;42:71-78. [PMID: 22109896 DOI: 10.1007/s12016-011-8291-x] [Cited by in Crossref: 150] [Cited by in F6Publishing: 131] [Article Influence: 16.7] [Reference Citation Analysis]
148 Vehik K, Ajami NJ, Hadley D, Petrosino JF, Burkhardt BR. The changing landscape of type 1 diabetes: recent developments and future frontiers. Curr Diab Rep 2013;13:642-50. [PMID: 23912764 DOI: 10.1007/s11892-013-0406-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
149 Bettini M, Vignali DA. T cell-driven initiation and propagation of autoimmune diabetes. Curr Opin Immunol 2011;23:754-60. [PMID: 22056379 DOI: 10.1016/j.coi.2011.10.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
150 Sun T, Liang H, Xue M, Liu Y, Gong A, Jiang Y, Qin Y, Yang J, Meng D. Protective effect and mechanism of fucoidan on intestinal mucosal barrier function in NOD mice. Food and Agricultural Immunology 2020;31:939-53. [DOI: 10.1080/09540105.2020.1789071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
151 Gianchecchi E, Fierabracci A. Recent Advances on Microbiota Involvement in the Pathogenesis of Autoimmunity. Int J Mol Sci. 2019;20. [PMID: 30642013 DOI: 10.3390/ijms20020283] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 11.5] [Reference Citation Analysis]
152 Li N, Hatch M, Wasserfall CH, Douglas-Escobar M, Atkinson MA, Schatz DA, Neu J. Butyrate and type 1 diabetes mellitus: can we fix the intestinal leak? J Pediatr Gastroenterol Nutr 2010;51:414-7. [PMID: 20706153 DOI: 10.1097/MPG.0b013e3181dd913a] [Cited by in Crossref: 26] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
153 Dirajlal-Fargo S, Albar Z, Bowman E, Labbato D, Sattar A, Karungi C, Longenecker CT, Nazzinda R, Funderburg N, Kityo C, Musiime V, McComsey GA. Subclinical Vascular Disease in Children With Human Immunodeficiency Virus in Uganda Is Associated With Intestinal Barrier Dysfunction. Clin Infect Dis 2020;71:3025-32. [PMID: 31807748 DOI: 10.1093/cid/ciz1141] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
154 Kim AS, Ko HJ. Plasma concentrations of zonulin are elevated in obese men with fatty liver disease. Diabetes Metab Syndr Obes 2018;11:149-57. [PMID: 29719415 DOI: 10.2147/DMSO.S163062] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
155 Demin OO, Smirnov SV, Sokolov VV, Cucurull-Sanchez L, Pichardo-Almarza C, Flores MV, Benson N, Demin OV. Modeling of celiac disease immune response and the therapeutic effect of potential drugs. BMC Syst Biol 2013;7:56. [PMID: 23826972 DOI: 10.1186/1752-0509-7-56] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
156 Vogt LM, Meyer D, Pullens G, Faas MM, Venema K, Ramasamy U, Schols HA, de Vos P. Toll-like receptor 2 activation by β2→1-fructans protects barrier function of T84 human intestinal epithelial cells in a chain length-dependent manner. J Nutr 2014;144:1002-8. [PMID: 24790027 DOI: 10.3945/jn.114.191643] [Cited by in Crossref: 57] [Cited by in F6Publishing: 46] [Article Influence: 8.1] [Reference Citation Analysis]
157 Sorini C, Cosorich I, Lo Conte M, De Giorgi L, Facciotti F, Lucianò R, Rocchi M, Ferrarese R, Sanvito F, Canducci F, Falcone M. Loss of gut barrier integrity triggers activation of islet-reactive T cells and autoimmune diabetes. Proc Natl Acad Sci U S A 2019;116:15140-9. [PMID: 31182588 DOI: 10.1073/pnas.1814558116] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 24.0] [Reference Citation Analysis]
158 Wolters VM, Xu W, Zhao X, Walters TD, Griffiths AM, Silverberg MS, Muise AM. Replication of genetic variation in the MYO9B gene in Crohn's disease. Hum Immunol 2011;72:592-7. [PMID: 21515326 DOI: 10.1016/j.humimm.2011.03.025] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
159 Diamanti A, Capriati T, Bizzarri C, Ferretti F, Ancinelli M, Romano F, Perilli A, Laureti F, Locatelli M. Autoimmune diseases and celiac disease which came first: genotype or gluten? Expert Review of Clinical Immunology 2015;12:67-77. [DOI: 10.1586/1744666x.2016.1095091] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
160 Yuan JH, Xie QS, Chen GC, Huang CL, Yu T, Chen QK, Li JY. Impaired intestinal barrier function in type 2 diabetic patients measured by serum LPS, Zonulin, and IFABP. J Diabetes Complications 2021;35:107766. [PMID: 33168395 DOI: 10.1016/j.jdiacomp.2020.107766] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
161 Lamprecht M, Bogner S, Schippinger G, Steinbauer K, Fankhauser F, Hallstroem S, Schuetz B, Greilberger JF. Probiotic supplementation affects markers of intestinal barrier, oxidation, and inflammation in trained men; a randomized, double-blinded, placebo-controlled trial. J Int Soc Sports Nutr 2012;9:45. [PMID: 22992437 DOI: 10.1186/1550-2783-9-45] [Cited by in Crossref: 122] [Cited by in F6Publishing: 102] [Article Influence: 13.6] [Reference Citation Analysis]
162 Tripathi A, Lammers KM, Goldblum S, Shea-Donohue T, Netzel-Arnett S, Buzza MS, Antalis TM, Vogel SN, Zhao A, Yang S, Arrietta MC, Meddings JB, Fasano A. Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proc Natl Acad Sci U S A 2009;106:16799-804. [PMID: 19805376 DOI: 10.1073/pnas.0906773106] [Cited by in Crossref: 209] [Cited by in F6Publishing: 182] [Article Influence: 17.4] [Reference Citation Analysis]
163 Mishra A, Prakash S, Sreenivas V, Das TK, Ahuja V, Gupta SD, Makharia GK. Structural and Functional Changes in the Tight Junctions of Asymptomatic and Serology-negative First-degree Relatives of Patients With Celiac Disease. J Clin Gastroenterol. 2016;50:551-560. [PMID: 26535478 DOI: 10.1097/mcg.0000000000000436] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
164 Sapone A, Lammers KM, Mazzarella G, Mikhailenko I, Cartenì M, Casolaro V, Fasano A. Differential mucosal IL-17 expression in two gliadin-induced disorders: gluten sensitivity and the autoimmune enteropathy celiac disease. Int Arch Allergy Immunol. 2010;152:75-80. [PMID: 19940509 DOI: 10.1159/000260087] [Cited by in Crossref: 156] [Cited by in F6Publishing: 120] [Article Influence: 13.0] [Reference Citation Analysis]
165 Fasano A. Intestinal permeability and its regulation by zonulin: diagnostic and therapeutic implications. Clin Gastroenterol Hepatol. 2012;10:1096-1100. [PMID: 22902773 DOI: 10.1016/j.cgh.2012.08.012] [Cited by in Crossref: 142] [Cited by in F6Publishing: 130] [Article Influence: 15.8] [Reference Citation Analysis]
166 Łoniewska B, Adamek K, Węgrzyn D, Kaczmarczyk M, Skonieczna-Żydecka K, Clark J, Adler G, Tousty J, Uzar I, Tousty P, Łoniewski I. Analysis of Faecal Zonulin and Calprotectin Concentrations in Healthy Children During the First Two Years of Life. An Observational Prospective Cohort Study. J Clin Med 2020;9:E777. [PMID: 32178435 DOI: 10.3390/jcm9030777] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
167 Rizzetto L, Fava F, Tuohy KM, Selmi C. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex. J Autoimmun 2018;92:12-34. [PMID: 29861127 DOI: 10.1016/j.jaut.2018.05.008] [Cited by in Crossref: 88] [Cited by in F6Publishing: 72] [Article Influence: 29.3] [Reference Citation Analysis]
168 Zuo T, He X, Cao L, Xue C, Tang Q. The dietary polysaccharide from Ommastrephes bartrami prevents chemotherapeutic mucositis by promoting the gene expression of antimicrobial peptides in Paneth cells. Journal of Functional Foods 2015;12:530-9. [DOI: 10.1016/j.jff.2014.12.015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
169 Ramezani Ahmadi A, Sadeghian M, Alipour M, Ahmadi Taheri S, Rahmani S, Abbasnezhad A. The Effects of Probiotic/Synbiotic on Serum Level of Zonulin as a Biomarker of Intestinal Permeability: A Systematic Review and Meta-Analysis. Iran J Public Health 2020;49:1222-31. [PMID: 33083288 DOI: 10.18502/ijph.v49i7.3575] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
170 Uibo R, Panarina M, Teesalu K, Talja I, Sepp E, Utt M, Mikelsaar M, Heilman K, Uibo O, Vorobjova T. Celiac disease in patients with type 1 diabetes: a condition with distinct changes in intestinal immunity? Cell Mol Immunol. 2011;8:150-156. [PMID: 21317917 DOI: 10.1038/cmi.2010.66] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
171 Łoniewska B, Węgrzyn D, Adamek K, Kaczmarczyk M, Skonieczna-Żydecka K, Adler G, Jankowska A, Uzar I, Kordek A, Celewicz M, Łoniewski I. The Influence of Maternal-Foetal Parameters on Concentrations of Zonulin and Calprotectin in the Blood and Stool of Healthy Newborns during the First Seven Days of Life. An Observational Prospective Cohort Study. J Clin Med 2019;8:E473. [PMID: 30959960 DOI: 10.3390/jcm8040473] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
172 Russo F, Linsalata M, Clemente C, D'Attoma B, Orlando A, Campanella G, Giotta F, Riezzo G. The effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study. BMC Cancer 2013;13:56. [PMID: 23379680 DOI: 10.1186/1471-2407-13-56] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
173 Galipeau HJ, Rulli NE, Jury J, Huang X, Araya R, Murray JA, David CS, Chirdo FG, McCoy KD, Verdu EF. Sensitization to gliadin induces moderate enteropathy and insulitis in nonobese diabetic-DQ8 mice. J Immunol 2011;187:4338-46. [PMID: 21911598 DOI: 10.4049/jimmunol.1100854] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 4.1] [Reference Citation Analysis]
174 Opazo MC, Ortega-Rocha EM, Coronado-Arrázola I, Bonifaz LC, Boudin H, Neunlist M, Bueno SM, Kalergis AM, Riedel CA. Intestinal Microbiota Influences Non-intestinal Related Autoimmune Diseases. Front Microbiol 2018;9:432. [PMID: 29593681 DOI: 10.3389/fmicb.2018.00432] [Cited by in Crossref: 81] [Cited by in F6Publishing: 55] [Article Influence: 27.0] [Reference Citation Analysis]
175 Klaus DA, Motal MC, Burger-Klepp U, Marschalek C, Schmidt EM, Lebherz-Eichinger D, Krenn CG, Roth GA. Increased plasma zonulin in patients with sepsis. Biochem Med (Zagreb). 2013;23:107-111. [PMID: 23457771 DOI: 10.11613/bm.2013.013] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
176 Patterson E, Marques TM, O'Sullivan O, Fitzgerald P, Fitzgerald GF, Cotter PD, Dinan TG, Cryan JF, Stanton C, Ross RP. Streptozotocin-induced type-1-diabetes disease onset in Sprague-Dawley rats is associated with an altered intestinal microbiota composition and decreased diversity. Microbiology (Reading) 2015;161:182-93. [PMID: 25370749 DOI: 10.1099/mic.0.082610-0] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 6.4] [Reference Citation Analysis]
177 Simpson M, Mojibian M, Barriga K, Scott FW, Fasano A, Rewers M, Norris JM. An exploration of Glo-3A antibody levels in children at increased risk for type 1 diabetes mellitus. Pediatr Diabetes 2009;10:563-72. [PMID: 19622083 DOI: 10.1111/j.1399-5448.2009.00541.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
178 Antvorskov JC, Josefsen K, Engkilde K, Funda DP, Buschard K. Dietary gluten and the development of type 1 diabetes. Diabetologia. 2014;57:1770-1780. [PMID: 24871322 DOI: 10.1007/s00125-014-3265-1] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 6.3] [Reference Citation Analysis]
179 Moludi J, Maleki V, Jafari‐vayghyan H, Vaghef‐mehrabany E, Alizadeh M. Metabolic endotoxemia and cardiovascular disease: A systematic review about potential roles of prebiotics and probiotics. Clin Exp Pharmacol Physiol 2020;47:927-39. [DOI: 10.1111/1440-1681.13250] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 20.0] [Reference Citation Analysis]
180 Cetin Z, Kosem A, Can B, Baser O, Catak M, Turhan T, Berker D. Serum zonulin level is not elevated in patients with polycystic ovary syndrome without metabolic syndrome. Arch Gynecol Obstet 2019;300:1785-90. [PMID: 31667610 DOI: 10.1007/s00404-019-05345-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
181 Fasano A. All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases. F1000Res 2020;9:F1000 Faculty Rev-69. [PMID: 32051759 DOI: 10.12688/f1000research.20510.1] [Cited by in Crossref: 55] [Cited by in F6Publishing: 39] [Article Influence: 55.0] [Reference Citation Analysis]
182 Flanagan J, Arjomandi A, Delanoy M, Du Paty E, Galea P, Laune D, Rieunier F, Walker R, Binder S. Development of monoclonal antibodies to pre-haptoglobin 2 and their use in an enzyme-linked immunosorbent assay (ELISA). Journal of Immunological Methods 2014;406:34-42. [DOI: 10.1016/j.jim.2014.02.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
183 Jayashree B, Bibin YS, Prabhu D, Shanthirani CS, Gokulakrishnan K, Lakshmi BS, Mohan V, Balasubramanyam M. Increased circulatory levels of lipopolysaccharide (LPS) and zonulin signify novel biomarkers of proinflammation in patients with type 2 diabetes. Mol Cell Biochem. 2014;388:203-210. [PMID: 24347174 DOI: 10.1007/s11010-013-1911-4] [Cited by in Crossref: 167] [Cited by in F6Publishing: 139] [Article Influence: 20.9] [Reference Citation Analysis]
184 Epeldegui M, Hussain SK. The Role of Microbial Translocation and Immune Activation in AIDS-Associated Non-Hodgkin Lymphoma Pathogenesis: What Have We Learned? Crit Rev Immunol 2020;40:41-51. [PMID: 32421978 DOI: 10.1615/CritRevImmunol.2020033319] [Reference Citation Analysis]
185 Liu Y, Lou X. Type 2 diabetes mellitus-related environmental factors and the gut microbiota: emerging evidence and challenges. Clinics (Sao Paulo) 2020;75:e1277. [PMID: 31939557 DOI: 10.6061/clinics/2020/e1277] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
186 McCole DF. IBD candidate genes and intestinal barrier regulation. Inflamm Bowel Dis. 2014;20:1829-1849. [PMID: 25215613 DOI: 10.1097/mib.0000000000000090] [Cited by in Crossref: 84] [Cited by in F6Publishing: 43] [Article Influence: 14.0] [Reference Citation Analysis]
187 Daft JG, Lorenz RG. Role of the gastrointestinal ecosystem in the development of type 1 diabetes. Pediatr Diabetes 2015;16:407-18. [PMID: 25952017 DOI: 10.1111/pedi.12282] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
188 Hałasa M, Maciejewska D, Ryterska K, Baśkiewicz-Hałasa M, Safranow K, Stachowska E. Assessing the Association of Elevated Zonulin Concentration in Stool with Increased Intestinal Permeability in Active Professional Athletes. Medicina (Kaunas) 2019;55:E710. [PMID: 31640273 DOI: 10.3390/medicina55100710] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
189 de Roos NM, van Hemert S, Rovers JMP, Smits MG, Witteman BJM. The effects of a multispecies probiotic on migraine and markers of intestinal permeability-results of a randomized placebo-controlled study. Eur J Clin Nutr. 2017;71:1455-1462. [PMID: 28537581 DOI: 10.1038/ejcn.2017.57] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
190 Castillo NE, Theethira TG, Leffler DA. The present and the future in the diagnosis and management of celiac disease. Gastroenterol Rep (Oxf) 2015;3:3-11. [PMID: 25326000 DOI: 10.1093/gastro/gou065] [Cited by in Crossref: 54] [Cited by in F6Publishing: 38] [Article Influence: 7.7] [Reference Citation Analysis]
191 Loffredo L, Zicari AM, Perri L, Carnevale R, Nocella C, Angelico F, Del Ben M, Mosca A, Zaffina S, Panera N, Alisi A, Duse M, Violi F, Nobili V. Does Nox2 Overactivate in Children with Nonalcoholic Fatty Liver Disease? Antioxid Redox Signal 2019;30:1325-30. [PMID: 30019598 DOI: 10.1089/ars.2018.7596] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
192 Brown K, DeCoffe D, Molcan E, Gibson DL. Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients. 2012;4:1095-1119. [PMID: 23016134 DOI: 10.3390/nu4081095] [Cited by in Crossref: 339] [Cited by in F6Publishing: 280] [Article Influence: 37.7] [Reference Citation Analysis]
193 Scott FW, Pound LD, Patrick C, Eberhard CE, Crookshank JA. Where genes meet environment-integrating the role of gut luminal contents, immunity and pancreas in type 1 diabetes. Transl Res 2017;179:183-98. [PMID: 27677687 DOI: 10.1016/j.trsl.2016.09.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
194 Pacifico L, Bonci E, Marandola L, Romaggioli S, Bascetta S, Chiesa C. Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease. World J Gastroenterol. 2014;20:17107-17114. [PMID: 25493023 DOI: 10.3748/wjg.v20.i45.17107] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
195 Leech B, Schloss J, Steel A. Association between increased intestinal permeability and disease: A systematic review. Advances in Integrative Medicine 2019;6:23-34. [DOI: 10.1016/j.aimed.2018.08.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 4.5] [Reference Citation Analysis]
196 Liu Z, Li C, Huang M, Tong C, Zhang X, Wang L, Peng H, Lan P, Zhang P, Huang N, Peng J, Wu X, Luo Y, Qin H, Kang L, Wang J. Positive regulatory effects of perioperative probiotic treatment on postoperative liver complications after colorectal liver metastases surgery: a double-center and double-blind randomized clinical trial. BMC Gastroenterol 2015;15:34. [PMID: 25881090 DOI: 10.1186/s12876-015-0260-z] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
197 Mouries J, Brescia P, Silvestri A, Spadoni I, Sorribas M, Wiest R, Mileti E, Galbiati M, Invernizzi P, Adorini L, Penna G, Rescigno M. Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development. J Hepatol. 2019;71:1216-1228. [PMID: 31419514 DOI: 10.1016/j.jhep.2019.08.005] [Cited by in Crossref: 103] [Cited by in F6Publishing: 94] [Article Influence: 51.5] [Reference Citation Analysis]
198 Hansen CHF, Larsen CS, Petersson HO, Zachariassen LF, Vegge A, Lauridsen C, Kot W, Krych Ł, Nielsen DS, Hansen AK. Targeting gut microbiota and barrier function with prebiotics to alleviate autoimmune manifestations in NOD mice. Diabetologia 2019;62:1689-700. [PMID: 31139852 DOI: 10.1007/s00125-019-4910-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 11.0] [Reference Citation Analysis]
199 Brown K, Godovannyi A, Ma C, Zhang Y, Ahmadi-Vand Z, Dai C, Gorzelak MA, Chan Y, Chan JM, Lochner A, Dutz JP, Vallance BA, Gibson DL. Prolonged antibiotic treatment induces a diabetogenic intestinal microbiome that accelerates diabetes in NOD mice. ISME J. 2016;10:321-332. [PMID: 26274050 DOI: 10.1038/ismej.2015.114] [Cited by in Crossref: 97] [Cited by in F6Publishing: 85] [Article Influence: 16.2] [Reference Citation Analysis]
200 Vojdani A, Vojdani E, Kharrazian D. Fluctuation of zonulin levels in blood vs stability of antibodies. World J Gastroenterol 2017;23:5669-79. [PMID: 28883692 DOI: 10.3748/wjg.v23.i31.5669] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 14] [Article Influence: 7.7] [Reference Citation Analysis]
201 Knip M. Diet, gut, and type 1 diabetes: role of wheat-derived peptides? Diabetes 2009;58:1723-4. [PMID: 19638529 DOI: 10.2337/db09-0686] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
202 Tillett BJ, Hamilton-Williams EE. Microbiota derived factors as drivers of type 1 diabetes. Prog Mol Biol Transl Sci 2020;171:215-35. [PMID: 32475523 DOI: 10.1016/bs.pmbts.2020.04.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
203 Visser JT, Bos NA, Harthoorn LF, Stellaard F, Beijer-Liefers S, Rozing J, van Tol EA. Potential mechanisms explaining why hydrolyzed casein-based diets outclass single amino acid-based diets in the prevention of autoimmune diabetes in diabetes-prone BB rats. Diabetes Metab Res Rev 2012;28:505-13. [PMID: 22539454 DOI: 10.1002/dmrr.2311] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
204 Ho J, Nicolucci AC, Virtanen H, Schick A, Meddings J, Reimer RA, Huang C. Effect of Prebiotic on Microbiota, Intestinal Permeability, and Glycemic Control in Children With Type 1 Diabetes. J Clin Endocrinol Metab 2019;104:4427-40. [PMID: 31188437 DOI: 10.1210/jc.2019-00481] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 25.0] [Reference Citation Analysis]
205 Vaarala O, Atkinson MA, Neu J. The “perfect storm” for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes. 2008;57:2555-2562. [PMID: 18820210 DOI: 10.2337/db08-0331] [Cited by in Crossref: 329] [Cited by in F6Publishing: 282] [Article Influence: 25.3] [Reference Citation Analysis]
206 Arrieta MC, Madsen K, Doyle J, Meddings J. Reducing small intestinal permeability attenuates colitis in the IL10 gene-deficient mouse. Gut. 2009;58:41-48. [PMID: 18829978 DOI: 10.1136/gut.2008.150888] [Cited by in Crossref: 176] [Cited by in F6Publishing: 165] [Article Influence: 13.5] [Reference Citation Analysis]
207 Assimakopoulos SF, Akinosoglou K, de Lastic A, Skintzi A, Mouzaki A, Gogos CA. The Prognostic Value of Endotoxemia and Intestinal Barrier Biomarker ZO-1 in Bacteremic Sepsis. The American Journal of the Medical Sciences 2020;359:100-7. [DOI: 10.1016/j.amjms.2019.10.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
208 Zhang D, Zhang L, Zheng Y, Yue F, Russell RD, Zeng Y. Circulating zonulin levels in newly diagnosed Chinese type 2 diabetes patients. Diabetes Res Clin Pract 2014;106:312-8. [PMID: 25238913 DOI: 10.1016/j.diabres.2014.08.017] [Cited by in Crossref: 51] [Cited by in F6Publishing: 41] [Article Influence: 7.3] [Reference Citation Analysis]
209 Kılıç F, Işık Ü, Demirdaş A, Doğuç DK, Bozkurt M. Serum zonulin and claudin-5 levels in patients with bipolar disorder. J Affect Disord 2020;266:37-42. [PMID: 32056901 DOI: 10.1016/j.jad.2020.01.117] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
210 Núñez C, Márquez A, Varadé J, Martínez A, Polanco I, Maluenda C, Fernández-arquero M, de la Concha EG, Urcelay E. No evidence of association of the MYO9B polymorphisms with celiac disease in the Spanish population. Tissue Antigens 2006;68:489-92. [DOI: 10.1111/j.1399-0039.2006.00699.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
211 Li X, Atkinson MA. The role for gut permeability in the pathogenesis of type 1 diabetes--a solid or leaky concept? Pediatr Diabetes 2015;16:485-92. [PMID: 26269193 DOI: 10.1111/pedi.12305] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 10.8] [Reference Citation Analysis]
212 Dib SA, Gomes MB. Etiopathogenesis of type 1 diabetes mellitus: prognostic factors for the evolution of residual beta cell function. Diabetol Metab Syndr 2009;1:25. [PMID: 19961609 DOI: 10.1186/1758-5996-1-25] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
213 Del Bo' C, Bernardi S, Cherubini A, Porrini M, Gargari G, Hidalgo-Liberona N, González-Domínguez R, Zamora-Ros R, Peron G, Marino M, Gigliotti L, Winterbone MS, Kirkup B, Kroon PA, Andres-Lacueva C, Guglielmetti S, Riso P. A polyphenol-rich dietary pattern improves intestinal permeability, evaluated as serum zonulin levels, in older subjects: The MaPLE randomised controlled trial. Clin Nutr 2021;40:3006-18. [PMID: 33388204 DOI: 10.1016/j.clnu.2020.12.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
214 Lee AS, Gibson DL, Zhang Y, Sham HP, Vallance BA, Dutz JP. Gut barrier disruption by an enteric bacterial pathogen accelerates insulitis in NOD mice. Diabetologia 2010;53:741-8. [DOI: 10.1007/s00125-009-1626-y] [Cited by in Crossref: 86] [Cited by in F6Publishing: 74] [Article Influence: 7.2] [Reference Citation Analysis]
215 Pärtty A, Kalliomäki M, Salminen S, Isolauri E. Infantile Colic Is Associated With Low-grade Systemic Inflammation. J Pediatr Gastroenterol Nutr 2017;64:691-5. [PMID: 27478897 DOI: 10.1097/MPG.0000000000001340] [Cited by in Crossref: 26] [Cited by in F6Publishing: 11] [Article Influence: 8.7] [Reference Citation Analysis]
216 Mokkala K, Pussinen P, Houttu N, Koivuniemi E, Vahlberg T, Laitinen K. The impact of probiotics and n-3 long-chain polyunsaturated fatty acids on intestinal permeability in pregnancy: a randomised clinical trial. Benef Microbes. 2018;9:199-208. [PMID: 29345158 DOI: 10.3920/bm2017.0072] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
217 Lammers KM, Lu R, Brownley J, Lu B, Gerard C, Thomas K, Rallabhandi P, Shea-Donohue T, Tamiz A, Alkan S. Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology. 2008;135:194-204.e3. [PMID: 18485912 DOI: 10.1053/j.gastro.2008.03.023] [Cited by in Crossref: 278] [Cited by in F6Publishing: 236] [Article Influence: 21.4] [Reference Citation Analysis]
218 Teshima CW, Meddings JB. The measurement and clinical significance of intestinal permeability. Curr Gastroenterol Rep 2008;10:443-9. [PMID: 18799118 DOI: 10.1007/s11894-008-0083-y] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
219 Hendy OM, Elsabaawy MM, Aref MM, Khalaf FM, Oda AMA, El Shazly HM. Evaluation of circulating zonulin as a potential marker in the pathogenesis of nonalcoholic fatty liver disease. APMIS 2017;125:607-13. [DOI: 10.1111/apm.12696] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
220 Mønsted MØ, Falck ND, Pedersen K, Buschard K, Holm LJ, Haupt-Jorgensen M. Intestinal permeability in type 1 diabetes: An updated comprehensive overview. J Autoimmun 2021;122:102674. [PMID: 34182210 DOI: 10.1016/j.jaut.2021.102674] [Reference Citation Analysis]
221 Özyurt G, Öztürk Y, Appak YÇ, Arslan FD, Baran M, Karakoyun İ, Tufan AE, Pekcanlar AA. Increased zonulin is associated with hyperactivity and social dysfunctions in children with attention deficit hyperactivity disorder. Compr Psychiatry 2018;87:138-42. [PMID: 30414552 DOI: 10.1016/j.comppsych.2018.10.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
222 Davalli AM, Perego C, Folli FB. The potential role of glutamate in the current diabetes epidemic. Acta Diabetol 2012;49:167-83. [DOI: 10.1007/s00592-011-0364-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
223 Assimakopoulos SF, Mastronikolis S, DE Lastic AL, Aretha D, Papageorgiou D, Chalkidi T, Oikonomou I, Triantos C, Mouzaki A, Marangos M. Intestinal Barrier Biomarker ZO1 and Endotoxin Are Increased in Blood of Patients With COVID-19-associated Pneumonia. In Vivo 2021;35:2483-8. [PMID: 34182534 DOI: 10.21873/invivo.12528] [Reference Citation Analysis]
224 You Q, He DM, Shu GF, Cao B, Xia YQ, Xing Y, Ni M, Chen JF, Shi SL, Gu HF, Liu Y, Wu J. Increased formation of neutrophil extracellular traps is associated with gut leakage in patients with type 1 but not type 2 diabetes. J Diabetes 2019;11:665-73. [PMID: 30592146 DOI: 10.1111/1753-0407.12892] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
225 Häger J, Bang H, Hagen M, Frech M, Träger P, Sokolova MV, Steffen U, Tascilar K, Sarter K, Schett G, Rech J, Zaiss MM. The Role of Dietary Fiber in Rheumatoid Arthritis Patients: A Feasibility Study. Nutrients 2019;11:E2392. [PMID: 31591345 DOI: 10.3390/nu11102392] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 11.5] [Reference Citation Analysis]
226 Hadjiyanni I, Li KK, Drucker DJ. Glucagon-like peptide-2 reduces intestinal permeability but does not modify the onset of type 1 diabetes in the nonobese diabetic mouse. Endocrinology. 2009;150:592-599. [PMID: 18845625 DOI: 10.1210/en.2008-1228] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
227 Leonard MM, Camhi S, Kenyon V, Betensky RA, Sturgeon C, Yan S, Fasano A. Targeted genotyping for the prediction of celiac disease autoimmunity development in patients with type 1 diabetes and their family members. World J Diabetes 2019;10:189-99. [PMID: 30891154 DOI: 10.4239/wjd.v10.i3.189] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
228 Caviglia GP, Rosso C, Ribaldone DG, Dughera F, Fagoonee S, Astegiano M, Pellicano R. Physiopathology of intestinal barrier and the role of zonulin. Minerva Biotecnol 2019;31. [DOI: 10.23736/s1120-4826.19.02554-0] [Cited by in Crossref: 41] [Article Influence: 20.5] [Reference Citation Analysis]
229 Hamari S, Kirveskoski T, Glumoff V, Kulmala P, Simell O, Knip M, Ilonen J, Veijola R. CD4⁺ T-cell proliferation responses to wheat polypeptide stimulation in children at different stages of type 1 diabetes autoimmunity. Pediatr Diabetes 2015;16:177-88. [PMID: 25643742 DOI: 10.1111/pedi.12256] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
230 Seethaler B, Basrai M, Neyrinck AM, Nazare JA, Walter J, Delzenne NM, Bischoff SC. Biomarkers for assessment of intestinal permeability in clinical practice. Am J Physiol Gastrointest Liver Physiol 2021;321:G11-7. [PMID: 34009040 DOI: 10.1152/ajpgi.00113.2021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
231 Kolyva S, Triga M, Kritikou D, Chrysis D. The effect of feeding patterns on serum zonulin levels in infants at 3-4 months of age. Eur J Pediatr 2021. [PMID: 33973070 DOI: 10.1007/s00431-021-04102-2] [Reference Citation Analysis]
232 Karakuła-Juchnowicz H, Szachta P, Opolska A, Morylowska-Topolska J, Gałęcka M, Juchnowicz D, Krukow P, Lasik Z. The role of IgG hypersensitivity in the pathogenesis and therapy of depressive disorders. Nutr Neurosci 2017;20:110-8. [PMID: 25268936 DOI: 10.1179/1476830514Y.0000000158] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
233 Zhou H, Sun L, Zhang S, Zhao X, Gang X, Wang G. Evaluating the Causal Role of Gut Microbiota in Type 1 Diabetes and Its Possible Pathogenic Mechanisms. Front Endocrinol (Lausanne) 2020;11:125. [PMID: 32265832 DOI: 10.3389/fendo.2020.00125] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 19.0] [Reference Citation Analysis]
234 Tran CD, Grice DM, Wade B, Kerr CA, Bauer DC, Li D, Hannan GN. Gut permeability, its interaction with gut microflora and effects on metabolic health are mediated by the lymphatics system, liver and bile acid. Future Microbiology 2015;10:1339-53. [DOI: 10.2217/fmb.15.54] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
235 Rios-Arce ND, Collins FL, Schepper JD, Steury MD, Raehtz S, Mallin H, Schoenherr DT, Parameswaran N, McCabe LR. Epithelial Barrier Function in Gut-Bone Signaling. Adv Exp Med Biol 2017;1033:151-83. [PMID: 29101655 DOI: 10.1007/978-3-319-66653-2_8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
236 Pellegrini S, Sordi V, Bolla AM, Saita D, Ferrarese R, Canducci F, Clementi M, Invernizzi F, Mariani A, Bonfanti R, Barera G, Testoni PA, Doglioni C, Bosi E, Piemonti L. Duodenal Mucosa of Patients With Type 1 Diabetes Shows Distinctive Inflammatory Profile and Microbiota. The Journal of Clinical Endocrinology & Metabolism 2017;102:1468-77. [DOI: 10.1210/jc.2016-3222] [Cited by in Crossref: 66] [Cited by in F6Publishing: 50] [Article Influence: 16.5] [Reference Citation Analysis]
237 Rouxel O, Da Silva J, Beaudoin L, Nel I, Tard C, Cagninacci L, Kiaf B, Oshima M, Diedisheim M, Salou M, Corbett A, Rossjohn J, McCluskey J, Scharfmann R, Battaglia M, Polak M, Lantz O, Beltrand J, Lehuen A. Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetes. Nat Immunol. 2017;18:1321-1331. [PMID: 28991267 DOI: 10.1038/ni.3854] [Cited by in Crossref: 115] [Cited by in F6Publishing: 97] [Article Influence: 28.8] [Reference Citation Analysis]
238 Mukherjee R, Kelly CP, Schuppan D. Nondietary therapies for celiac disease. Gastrointest Endosc Clin N Am 2012;22:811-31. [PMID: 23083995 DOI: 10.1016/j.giec.2012.09.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
239 Mojibian M, Chakir H, Lefebvre DE, Crookshank JA, Sonier B, Keely E, Scott FW. Diabetes-specific HLA-DR-restricted proinflammatory T-cell response to wheat polypeptides in tissue transglutaminase antibody-negative patients with type 1 diabetes. Diabetes 2009;58:1789-96. [PMID: 19401421 DOI: 10.2337/db08-1579] [Cited by in Crossref: 50] [Cited by in F6Publishing: 37] [Article Influence: 4.2] [Reference Citation Analysis]
240 Bibbò S, Dore MP, Pes GM, Delitala G, Delitala AP. Is there a role for gut microbiota in type 1 diabetes pathogenesis? Annals of Medicine 2017;49:11-22. [DOI: 10.1080/07853890.2016.1222449] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 7.6] [Reference Citation Analysis]
241 Vaarala O. Is the origin of type 1 diabetes in the gut? Immunol Cell Biol 2012;90:271-6. [PMID: 22290506 DOI: 10.1038/icb.2011.115] [Cited by in Crossref: 72] [Cited by in F6Publishing: 64] [Article Influence: 8.0] [Reference Citation Analysis]
242 Endesfelder D, Engel M, Zu Castell W. Gut Immunity and Type 1 Diabetes: a Mélange of Microbes, Diet, and Host Interactions? Curr Diab Rep 2016;16:60. [PMID: 27155610 DOI: 10.1007/s11892-016-0753-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
243 Harms RZ, Ostlund KR, Cabrera M, Edwards E, Smith VB, Smith LM, Sarvetnick N. Frequencies of CD8 and DN MAIT Cells Among Children Diagnosed With Type 1 Diabetes Are Similar to Age-Matched Controls. Front Immunol 2021;12:604157. [PMID: 33708202 DOI: 10.3389/fimmu.2021.604157] [Reference Citation Analysis]
244 González-González M, Díaz-Zepeda C, Eyzaguirre-Velásquez J, González-Arancibia C, Bravo JA, Julio-Pieper M. Investigating Gut Permeability in Animal Models of Disease. Front Physiol 2018;9:1962. [PMID: 30697168 DOI: 10.3389/fphys.2018.01962] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
245 Ohlsson B, Roth B, Larsson E, Höglund P. Calprotectin in serum and zonulin in serum and feces are elevated after introduction of a diet with lower carbohydrate content and higher fiber, fat and protein contents. Biomed Rep 2017;6:411-22. [PMID: 28413639 DOI: 10.3892/br.2017.865] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
246 Küçükemre Aydın B, Yıldız M, Akgün A, Topal N, Adal E, Önal H. Children with Hashimoto’s Thyroiditis Have Increased Intestinal Permeability: Results of a Pilot Study. J Clin Res Pediatr Endocrinol 2020;12:303-7. [PMID: 31990165 DOI: 10.4274/jcrpe.galenos.2020.2019.0186] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
247 Gu J, Su S, Guo J, Zhu Y, Zhao M, Duan J. The aerial parts of Salvia miltiorrhiza Bge. strengthen intestinal barrier and modulate gut microbiota imbalance in streptozocin-induced diabetic mice. Journal of Functional Foods 2017;36:362-74. [DOI: 10.1016/j.jff.2017.06.010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
248 Fasano A. Zonulin, regulation of tight junctions, and autoimmune diseases. Ann N Y Acad Sci. 2012;1258:25-33. [PMID: 22731712 DOI: 10.1111/j.1749-6632.2012.06538.x] [Cited by in Crossref: 142] [Cited by in F6Publishing: 105] [Article Influence: 15.8] [Reference Citation Analysis]
249 Sanz Y, Olivares M, Moya-Pérez Á, Agostoni C. Understanding the role of gut microbiome in metabolic disease risk. Pediatr Res 2015;77:236-44. [PMID: 25314581 DOI: 10.1038/pr.2014.170] [Cited by in Crossref: 68] [Cited by in F6Publishing: 48] [Article Influence: 9.7] [Reference Citation Analysis]
250 Li P, Yang XK, Wang X, Zhao MQ, Zhang C, Tao SS, Zhao W, Huang Q, Li LJ, Pan HF, Ye DQ. A meta-analysis of the relationship between MYO9B gene polymorphisms and susceptibility to Crohn's disease and ulcerative colitis. Hum Immunol 2016;77:990-6. [PMID: 27435931 DOI: 10.1016/j.humimm.2016.07.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
251 Ganda Mall JP, Casado-Bedmar M, Winberg ME, Brummer RJ, Schoultz I, Keita ÅV. A β-Glucan-Based Dietary Fiber Reduces Mast Cell-Induced Hyperpermeability in Ileum From Patients With Crohn's Disease and Control Subjects. Inflamm Bowel Dis 2017;24:166-78. [PMID: 29272475 DOI: 10.1093/ibd/izx002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
252 Loffredo L, Ivanov V, Ciobanu N, Deseatnicova E, Gutu E, Mudrea L, Ivanov M, Nocella C, Cammisotto V, Orlando F, Pannunzio A, Palumbo I, Cosenza M, Bartimoccia S, Carnevale R, Violi F. Is There an Association Between Atherosclerotic Burden, Oxidative Stress, and Gut-Derived Lipopolysaccharides? Antioxidants & Redox Signaling 2020;33:761-6. [DOI: 10.1089/ars.2020.8109] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
253 Caio G, Volta U, Sapone A, Leffler DA, De Giorgio R, Catassi C, Fasano A. Celiac disease: a comprehensive current review. BMC Med. 2019;17:142. [PMID: 31331324 DOI: 10.1186/s12916-019-1380-z] [Cited by in Crossref: 137] [Cited by in F6Publishing: 91] [Article Influence: 68.5] [Reference Citation Analysis]
254 Liu W, Luo X, Tang J, Mo Q, Zhong H, Zhang H, Feng F. A bridge for short-chain fatty acids to affect inflammatory bowel disease, type 1 diabetes, and non-alcoholic fatty liver disease positively: by changing gut barrier. Eur J Nutr 2021;60:2317-30. [PMID: 33180143 DOI: 10.1007/s00394-020-02431-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
255 Liśkiewicz P, Kaczmarczyk M, Misiak B, Wroński M, Bąba-kubiś A, Skonieczna-żydecka K, Marlicz W, Bieńkowski P, Misera A, Pełka-wysiecka J, Kucharska-mazur J, Konopka A, Łoniewski I, Samochowiec J. Analysis of gut microbiota and intestinal integrity markers of inpatients with major depressive disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2021;106:110076. [DOI: 10.1016/j.pnpbp.2020.110076] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
256 Tao S, Xiong Y, Han D, Pi Y, Zhang H, Wang J. N-(3-oxododecanoyl)-l-homoserine lactone disrupts intestinal epithelial barrier through triggering apoptosis and collapsing extracellular matrix and tight junction. J Cell Physiol 2021;236:5771-84. [PMID: 33400297 DOI: 10.1002/jcp.30261] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
257 King MA, Rollo I, Baker LB. Nutritional considerations to counteract gastrointestinal permeability during exertional heat stress. J Appl Physiol (1985) 2021;130:1754-65. [PMID: 33955260 DOI: 10.1152/japplphysiol.00072.2021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
258 Saitogullari N, Sayili U, Altunoglu E, Uzun H. Evaluation of serum zonulin level in prediabetic patients. Ann Endocrinol (Paris) 2021;82:1-7. [PMID: 33278377 DOI: 10.1016/j.ando.2020.11.004] [Reference Citation Analysis]
259 Isaacs SR, Foskett DB, Maxwell AJ, Ward EJ, Faulkner CL, Luo JYX, Rawlinson WD, Craig ME, Kim KW. Viruses and Type 1 Diabetes: From Enteroviruses to the Virome. Microorganisms 2021;9:1519. [PMID: 34361954 DOI: 10.3390/microorganisms9071519] [Reference Citation Analysis]
260 Marietta EV, Murray JA. Animal models to study gluten sensitivity. Semin Immunopathol 2012;34:497-511. [PMID: 22572887 DOI: 10.1007/s00281-012-0315-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
261 Vaquero L, Rodríguez-Martín L, León F, Jorquera F, Vivas S. New coeliac disease treatments and their complications. Gastroenterol Hepatol 2018;41:191-204. [PMID: 29422237 DOI: 10.1016/j.gastrohep.2017.12.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
262 Bona MD, Torres CHM, Lima SCVC, Lima AAM, Maciel BLL. Intestinal barrier function in obesity with or without metabolic syndrome: a systematic review protocol. BMJ Open 2021;11:e043959. [PMID: 34020973 DOI: 10.1136/bmjopen-2020-043959] [Reference Citation Analysis]